China News Service, May 30th. The National Health and Medical Commission held a press conference on the progress of maternal and child health work since the 18th National Congress of the Communist Party of China. At the meeting, it was introduced that five HPV vaccines have been approved for registration in our country, including three imported HPV vaccines and two domestic vaccines.
A reporter asked at the meeting: Cervical cancer can be prevented by HPV vaccination. What are the arrangements for countries to increase the HPV vaccination rate?
We are also concerned that many people report that they cannot get the HPV vaccine. How to meet the vaccination needs of school-age women?
In this regard, Wang Linhong said that cervical cancer and precancerous lesions now have very authoritative data showing that it is related to high-risk HPV infection.
Therefore, HPV vaccination for school-age women is an important measure to effectively prevent HPV infection and reduce the occurrence of cervical cancer.
At present, five HPV vaccines have been approved for registration in our country, including three imported HPV vaccines and two domestic vaccines.
According to the national routine vaccine report data, from 2018 to 2020, the number of HPV vaccinations has increased year by year, from 3.417 million in 2018 to 12.279 million doses in 2020.
But on the whole, the current HPV vaccine is still in short supply, and the number of our school-age women is still relatively large, so the HPV vaccination rate is still at a relatively low level.
Wang Linhong revealed that in recent years, the country has been actively strengthening the scientific publicity of HPV vaccination and promoting the pilot work of HPV vaccine.
In accordance with the work idea of overall advancement and key breakthroughs, the three provinces of Guangdong, Hainan and Fujian have been promoted to implement the work of free vaccination of school-age girls with domestic bivalent vaccines in the province, and this work has been included in the 2022 provincial party committee and government. s project.
Many other cities also use the platform of Healthy City to promote the pilot work of comprehensive cervical cancer prevention and control. For example, pilot cities such as Jinan, Xiamen, Wuxi, and Ordos have introduced the policy of free HPV vaccination for school-age girls, and Chengdu. A fixed amount of subsidy has been given to school-age girls for HPV vaccine to meet the different needs of service clients for HPV vaccine.
Wang Linhong said that the recent summary of the data shows that the coverage of HPV vaccination among junior high school girls in these pilot areas has been greatly improved, and some cities have reached more than 90%.
In the next step, we will summarize the pilots of the pilot program to promote the free HPV vaccination policy to cover more people, and also increase the multi-departmental collaboration to solve the problem of insufficient HPV vaccine supply and better meet the vaccination needs.
Wang Linhong also made some popular science for the majority of female friends: At present, the HPV vaccines available in our country include bivalent vaccine, quadrivalent vaccine and nine-valent vaccine, which are used by women in the age range of 9 to 45 years old, but they have a high risk of HPV causing cervical cancer. The most important types are subtypes 16 and 18, so the bivalent vaccine can prevent more than 70% of cervical cancers, which is the vast majority of cervical cancers.
Another important point is that the HPV vaccine has the best protective effect on adolescent girls who have not yet been infected with the virus. Therefore, the World Health Organization recommends girls aged 9 to 14 as the primary vaccination group. The earlier the vaccination, the better the effect.
Therefore, under the current situation of tight supply of HPV vaccines, there is no need to miss the best vaccination time because of waiting for higher-priced vaccines.